About Relay Therapeutics
Relay Therapeutics is a clinical-stage precision medicine company transforming drug discovery through its proprietary Dynamo platform. Unlike traditional drug discovery approaches that rely on static protein structures, Relay's technology enables visualization of protein motion in high-definition, allowing the company to more effectively target proteins that have been previously intractable or inadequately drugged. The company integrates leading-edge experimental and computational approaches to advance a pipeline of promising therapeutic candidates with an initial focus on precision oncology and genetic disease. Based in Cambridge, Massachusetts, Relay Therapeutics is a publicly traded company committed to bringing life-changing medicines to patients. The company's team is highly integrated, collaborative, and entrepreneurial, driven by a personal mission to develop treatments for diseases that have impacted many team members personally. Relay's motion-based drug design approach represents a fundamental shift in how drug discovery is conducted, creating new possibilities for targeting the 'undruggable' and advancing precision medicine.
Mission & Story
Mission
We are laser-focused on bringing life-changing medicines to patients
Clinical Focus
Medical conditions and clinical areas addressed by Relay Therapeutics.
Who It Serves
Milestones & Awards
Recent Milestones
Advancing pipeline of therapeutic candidates in clinical development
Company Details
- Headquarters
- Cambridge, MA, USA
Work here?
Claim this listing to update company information and connect with our audience.
Claim This ListingOfficial Sources
Similar Companies in this Market
View all 64 →
A2A Pharmaceuticals
AI-driven pharmaceutical company focused on discovering and developing novel drug candidates using computational biology and machine learning.
AbCellera
AbCellera uses AI and machine learning to discover and develop antibody-based therapeutics and vaccines.
Absci
Absci uses AI-powered computational biology and machine learning to accelerate drug discovery and optimize therapeutic proteins and antibodies.
Adaptyv Bio
11-50 employees
Adaptyv Bio operates the world's fastest protein validation lab, providing automated experimental testing services for AI-designed proteins. The company enables protein engineers to validate binding, expression, and thermostability of novel protein designs through a fully automated platform with 3-week turnaround times.
Aitia
Aitia is a drug discovery and development company leveraging AI and computational biology to identify novel therapeutic targets and accelerate drug development.
Anagenex
Anagenex is a biotechnology company focused on drug discovery and development. The company appears to operate in the pharmaceutical research space, though specific details about their technology platform, therapeutic areas, and target markets are not available from the provided content.
Aqemia
Aqemia is a drug discovery company advancing next-generation medicines using generative AI and deep physics. The company combines AI-augmented discovery with computational chemistry to develop novel therapeutics at scale.
Arctoris
51-200 employees
Arctoris is a Partnership Research Organisation (PRO) providing automated wet lab biology R&D and data generation services for biotech, techbio, and pharma companies through its Ulysses® robotic platform.
Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.